LOC113230 Inhibitors
LOC113230 inhibitors encompass a range of chemical compounds that interact with various cellular signaling pathways and biological processes which, when influenced, could lead to the functional inhibition of LOC113230. For example, compounds like LY294002 and Wortmannin are PI3K inhibitors that prevent the phosphorylation of PIP2 to PIP3, a critical step for the activation of the AKT pathway. Since LOC113230 might rely on PI3K/AKT signaling for its activity, inhibition of this pathway can lead to its functional suppression. Rapamycin, an mTOR inhibitor, acts by suppressing mTORC1 complex activity, which could reduce the activity of proteins that depend on mTORC1-mediated phosphorylation, including potentially LOC113230.
Moreover, inhibitors of the MAPK/ERK pathway, such as PD98059 and U0126, block the activation of ERK1/2. If LOC113230's activity is regulated through MAPK/ERK signaling, these inhibitors will effectively reduce its function. Similarly, SB203580 and SP600125 inhibit the p38 MAPK and JNK pathways, respectively. Inhibition of these pathways could lead to decreased activity of LOC113230 if it is modulated by or involved in stress response signaling mediated by p38 MAPK or JNK. Compounds like Brefeldin A disrupt protein trafficking, which could inhibit LOC113230 if proper cellular localization is crucial for its function. Energy metabolism inhibitors, such as 2-Deoxy-D-glucose and Palmitoyl-DL-carnitine, could also suppress LOC113230's activity if it is dependent on ATP or cellular energy levels. Lastly, the autophagy inhibitor 3-Methyladenine and lysosomal inhibitor Chloroquine could inhibit LOC113230 by preventing theturnover or degradation of cellular components that might regulate the protein's function.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor that prevents the activation of AKT by inhibiting phosphorylation of PIP2 to PIP3, which would be necessary for proper localization and function of LOC113230 in signaling pathways that rely on PI3K/AKT activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor that suppresses the mTORC1 complex, potentially reducing the activity of proteins that depend on mTORC1-mediated phosphorylation, including LOC113230 if it is a downstream effector. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Another PI3K inhibitor that blocks the PI3K/AKT pathway, which could prevent the phosphorylation and activation of proteins that are regulated by this pathway, thereby potentially inhibiting the function of LOC113230. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
MEK inhibitor that blocks the MAPK/ERK pathway, potentially reducing the phosphorylation of proteins that are part of this pathway, which could lead to the inhibition of LOC113230 if it is functionally connected to the MAPK/ERK signaling. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
p38 MAPK inhibitor that could reduce the activity of proteins that are phosphorylated in response to stress-activated p38 MAPK signaling, potentially inhibiting LOC113230 if it is associated with this pathway. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor that would prevent the activation of proteins involved in the JNK signaling pathway, potentially leading to the inhibition of LOC113230 if it is modulated by JNK signaling. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
MEK inhibitor that prevents the activation of ERK1/2, which could lead to the inhibition of LOC113230 if its activity is regulated by the MAPK/ERK pathway. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Inhibitor of ADP-ribosylation factor (ARF), potentially disrupting protein trafficking and localization, which could inhibit LOC113230 if its function is dependent on correct cellular localization. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $70.00 $215.00 | 26 | |
Glycolysis inhibitor that could reduce ATP levels, indirectly inhibiting proteins like LOC113230 if they require ATP for their activity. | ||||||
Autophagy Inhibitor, 3-MA | 5142-23-4 | sc-205596 sc-205596A | 50 mg 500 mg | $65.00 $261.00 | 113 | |
Autophagy inhibitor that could reduce the turnover of cellular components, potentially inhibiting LOC113230 if it is degraded or otherwise regulated by autophagic processes. | ||||||